A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
Clinical trial NCT02271503 · COMPLETED
Trial details
- NCT number
- NCT02271503
- Sponsor
- Impax Laboratories, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-08-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.